-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/horizon-scan_research-protocol.pdf
December 01, 2011 - Potential Patient and Clinical Staff Safety Issues
17. … Patient Safety Issues (if applicable)
15. Required Resources
16. … data from conferences or published articles reporting different results or
confirming efficacy and safety … Safety data that could change perspectives
c. … Has a patient safety alert been issued that could signal a safety/efficacy
change in perspectives?
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/gerd_executive.pdf
September 01, 2011 - publication
of approximately 3,000 new studies; the introduction of
novel drugs; the recognition of new drug safety … are made in
the report, its conclusions should have clinical
applicability because they laid out the safety … potential necessity for lifelong medical
therapy raises the possibility of unidentified long-
term safety … Therefore, systematic
monitoring of long-term safety data on PPIs
should be emphasized, as well as better … Administrative databases can
provide additional data for addressing long-term
safety issues.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/patient-centered-medical-home_executive.pdf
July 01, 2012 - variety of health care needs
of patients and to improve patient and staff
experiences, outcomes, safety … care that uses alternative methods
of communication, and a systems-based approach to
quality and safety … comprehensive PCMH
interventions hold promise as a pathway to improved
primary health care quality, safety … A systems-based approach to improving quality
and safety
3. … increased provider burden (e.g.,
enhanced access through 24/7 coverage and email) and
potential patient safety
-
effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1312.pdf
December 01, 2013 - and efficacy and the lack of
long-term data on safety and efficacy. … Additional
scrutiny of teduglutide’s safety and its impact on cost of care is likely going forward … However, other experts noted that clinicians may hesitate to perform this procedure until
more safety … Summary of safety and effectiveness data
(SSED). LINX reflux management system.
P100049. … The
LINX reflux management system: confirmed
safety and efficacy now at 4 years.
-
effectivehealthcare.ahrq.gov/sites/default/files/functional-limitations-horizon-scan-high-impact-1306.pdf
June 01, 2013 - Several experts thought safety concerns could be a barrier to clinician acceptance,
because device … Overall, this device’s
perceived complex nature, the existence of alternatives, and limited safety … Safety concerns could be a barrier to clinician acceptance, several experts
thought, because device … The device’s perceived complex nature,
the existence of comparators, and limited safety and efficacy … Safety and
performance evaluation of ReWalk reciprocating
gait orthosis (RGO).
-
effectivehealthcare.ahrq.gov/sites/default/files/ahrq-healthcare-horizon-scan-protocol-operations-manual_130826.pdf
August 01, 2013 - Potential Patient and Clinical Staff Safety Issues
14. … Patient Safety Issues (if applicable)
11. Required Resources
12. … data from conferences or published articles reporting different results or
confirming efficacy and safety … Safety data that could change perspectives
4. … A patient safety alert been issued that could signal a safety/efficacy change in
perspectives?
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/autism-update_clinician.pdf
September 01, 2014 - According to the United States Food and Drug
Administration, there are serious safety issues associated
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/public-reporting-quality-improvement_disposition-comments.pdf
July 26, 2012 - directions of public reporting -- for example,
in support of value-based purchasing, administration-wide safety … The report also highlights that public reporting should make
a distinction between quality and safety … precision of the evidence for public reporting
outcomes, with special focus on separating quality and
safety … repository that can contain information on public
reporting,
while separating data on quality and safety … take tremendous time from care-
givers on the front line and may actually detract from quality and safety
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/urinary-incontinence-treatment_executive.pdf
April 01, 2012 - Several retrospective observational studies
analyzed the long-term comparative effectiveness and
safety … safety was rarely available in RCTs, despite high
discontinuation rates suggesting that there were … drugs’ adverse
effects in clinical practice could provide information about
long-term comparative safety … • Evidence is insufficient for the long-term safety of
pharmacological treatments. … Safety profile of tolterodine as
used in general practice in England: results of prescription-event
-
effectivehealthcare.ahrq.gov/sites/default/files/crosscutting-horizon-scan-high-impact-1412.pdf
December 01, 2014 - Although propofol may be preferred for these
reasons, safety concerns complicate its use. … benefits of wider access to
ES-4
propofol-mediated sedation were significant enough to offset safety … The intent is to improve
seniors’ safety, clinical outcomes, and quality of care and to reduce admissions … The primary endpoint
was a composite safety measure (area under the curve of oxygen desaturation [AUCDesat … the Sedasys can be used.7
The FDA approval requires that EES conduct two postmarketing studies on safety
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/gout_executive-2016.pdf
January 01, 2016 - The safety of tests used to diagnose gout also needs to
be considered. … Potential safety concerns include acute
physical discomfort from joint aspiration and long-term
effects … Therefore, we have undertaken a systematic review of
studies examining the accuracy and safety of tests … The focus of this report is on evaluating the validity and
safety of existing diagnostic methods for … Summary of findings on comparative accuracy and safety
of gout diagnostic methods
Outcomes Level
-
effectivehealthcare.ahrq.gov/sites/default/files/s29.pdf
October 01, 2007 - They pointed out that if existing evidence suggested
that 2 or more drugs had comparable efficacy and safety … whether less expensive is as effective)
Would not be a significant factor; medication effectiveness and safety … Would not have similar evidence-base for both drugs; 1 yr not sufficient to evaluate
safety or side effect … Choose study drugs (treatment arms) for which there is no evidence of
differential effectiveness or safety
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/arthritis-knee-physical-therapy_research-protocol.pdf
April 01, 2010 - integration or
reintegration
Injury prevention or reduction with use of
devices and equipment
Safety … o Long-term outcomes (>3 months)
• Settings
Outpatient and home-based care settings
• Safety … We will monitor the FDA Web site for warnings and safety information
for all eligible devices. … Evidence-based Practice Center Systematic Review Protocol
Outpatient and home-based care settings
• Safety
-
effectivehealthcare.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-1506.pdf
June 01, 2015 - Novartis Pharmaceuticals. 16 week efficacy
and 2 year long term safety and efficacy of
secukinumab … Novartis Pharmaceuticals. 16 week efficacy
and 5 year long term efficacy, safety and
tolerability … anti-interleukin-17a
monoclonal antibody, improves active
psoriatic arthritis: 24-week efficacy and safety … antibody, improves active
psoriatic arthritis and inhibits radiographic
progression: efficacy and safety … 17a-monoclonal-antibody-improves-active-psoriatic-arthritis-and-inhibits-radiographic-progression-efficacy-and-safety-data-from-a-phase
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/urinary-incontinence-treatment_research-protocol.pdf
September 30, 2010 - Minnesota
Pulsegen device Certificate of Approval for Use of GS Symbol No. 95 44
083; LGA, Equipment Safety … Twin (Vitacon AS, Trondheim, Norway)
Vaginal cones Mabella cones (Vitacon AS, Trond-heim, Norway)
Safety … We will monitor the FDA website for warnings and safety information for all
eligible drugs and devices … will analyze the harmful effects of drugs from
all sources including efficacy, effectiveness, and safety … Clinical efficacy and safety of tolterodine in the treatment of overactive
bladder: a pooled analysis
-
effectivehealthcare.ahrq.gov/sites/default/files/01_arthritis_potential_high_impact_2012-12-10.pdf
January 01, 2012 - pricing than injectable biologic
therapies, but some experts expressed strong concerns regarding its safety … stated MSC therapy is
investigational because of insufficient evidence or insufficient long-term safety … Both groups had
similar safety profiles.
29
In a study of patients with knee OA (Outerbridge grades … such as a hospital
blood bank or blood processing laboratory) according to standard blood processing safety … These safety concerns could present significant barriers to diffusion.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/insulin-blood-sugar_research.pdf
August 01, 2015 - Study design:
Allocation: Randomized
Endpoint Classification:
Safety/Efficacy Study
Intervention … Study design:
Endpoint Classification: Safety
Study
Intervention Model: Single Group
Assignment … Study design:
Allocation: Randomized
Endpoint Classification:
Safety/Efficacy Study
Intervention … Study design:
Allocation: Randomized
Endpoint Classification:
Safety/Efficacy Study
Intervention … Study design:
Allocation: Randomized
Endpoint Classification:
Safety/Efficacy Study
Intervention
-
effectivehealthcare.ahrq.gov/sites/default/files/dementia_horizon-scan-high_impact-1306-revised.pdf
July 09, 2013 - some thought that knowing that a patient has AD could aid planning for
patients in terms of patient safety … florbetapir scan does not establish
a diagnosis of AD or other cognitive disorder, and florbetapir’s safety … the other hand, some experts
thought that having the diagnosis would enable planning for patient safety … They
thought that the drug’s well-known safety profile and long history of use (in diabetes) would … Safety and
effectiveness study of intranasal insulin glulisine
on cognitive and memory in mild-mod
-
effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1412.pdf
December 01, 2014 - Adoption could be limited by ketamine’s
cost, inconsistent clinical trial data, and safety risks, multiple … But one expert with a research
5
background, citing ketamine’s safety risk and lack of long-term … and clinician adoption, predicted that
acceptance would be limited; these experts cited ketamine’s safety … In
contrast, scopolamine’s known safety profile and possible oral and patch delivery options, bolstered … A
study to evaluate the safety and efficacy of
intranasal esketamine in treatment-resistant
depression
-
effectivehealthcare.ahrq.gov/sites/default/files/dementia_hi_impact.pdf
January 01, 2012 - the
other hand, some thought that knowing that a patient has AD could aid planning in terms of
safety … On
the other hand, some experts thought that having the diagnosis
would enable planing for safety … A diagnosis could, however aid patients and families in planning for the care
and safety of the patient